Docetaxel (Taxotere) appears to help improve overall quality of life and delay time for subsequent therapy in men with both non-metastatic and metastatic prostate cancer, according to a new analysis of STAMPEDE trial results.
Adding apalutamide prior to metastases may benefit men with prostate cancer who are no longer responding to androgen deprivation therapy, according to new phase III study findings.
Despite a recent study’s promise, downsides to the procedure remain, according to one of the study’s authors.
In renal stones smaller than 1.5 cm diameter, ureteroscopic lithotripsy (URS) is associated with superior stone-free rates compared with shock wave lithotripsy (SWL), according to a recent study.
Salvage extended pelvic lymph node dissection (ePLND) may be highly beneficial for selected prostate cancer patients with biochemical recurrence and clinically recurrent nodal disease, say German researchers.
Seattle-A new study suggests that a lower PSA threshold for considering
a prostate biopsy may improve the clinical value of the widely used test.
In addition, lowering the threshold for biopsy may be particularly important
for men under the age of 60 years, according to researchers from Brigham
and Women's Hospital in Boston and Washington University School of Medicine
in St. Louis.
Seattle-A retrospective review of patients with secondary azoospermia has uncovered an alarming tumor rate and a high sperm recovery rate, reiterating the importance of urologic evaluation in this population.
Seattle-Use of some over-the-counter herbal supplements may be adversely
affecting male fertility. In an ironic twist, those supplements touted as
helping with infertility appear to be among those doing harm.